Search Within

William K Kelly

Formats
  1. Journal Article (82)
  2. Meeting Abstract (25)
  3. Book Section (6)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (82)
  3. Genitourinary Oncology Service (81)
  4. Hematologic Malignancies, Division of (34)
  5. Nursing (31)
  6. GSK Faculty (24)

More Groups

People
  1. Howard Scher (76)
  2. Susan Slovin (31)
  3. Michael Morris (24)
  4. Tracy Smart-Curley (23)
  5. Lawrence Schwartz (20)
  6. Paul Marks (16)

More People

Years
  1. 2017 (1)
  2. 2016 (1)
  3. 2009 (2)
  4. 2007 (4)
  5. 2006 (4)
  6. 2005 (21)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Clinical Cancer Research (13)
  3. Urology (13)
  4. Cancer (9)
  5. Journal of Urology (5)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Elsevier Science, Inc. (20)
  3. American Association for Cancer Research (16)
  4. Elsevier Inc. (9)
  5. Wiley Blackwell (9)
  6. Lippincott Williams & Wilkins (4)

More Publishers

Results (115)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer - Discussion
    Journal Article

    Smith, M. R.; D'Amico, A. V.; Kelly, W. K.; Pollack, A.
    Urology (2002)

    Fulltext@MSK | Save
  • Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer - Discussion
    Journal Article

    Lee, W. R.; Pollak, A.; Carroll, P. R.; Klotz, L.; D'Amico, A. V.; Kelly, W. K.; Sartor, O.; Kantoff, P. W.
    Urology (2002)

    Fulltext@MSK | Save
  • Editorial: States and state transitions are all that really matter
    Journal Article

    Scher, H. I.; Kelly, W. K.
    Journal of Urology (2002)

    Fulltext@MSK | Save
  • Overview consensus statement
    Journal Article

    Carroll, P. R.; Kantoff, P. W.; Balk, S. P.; Brown, M. A.; D'Amico, A. V.; George, D. J.; Grossfeld, G. D.; Johnson, C. S.; Kelly, W. K.; Klotz, L.; more...
    Urology (2002)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors: From target to clinical trials
    Journal Article

    Kelly, W. K.; O'Connor, O. A.; Marks, P. A.
    Expert Opinion on Investigational Drugs (2002)

    Fulltext@MSK | Save
  • Quantifying the amount of variation in survival explained by prostate-specific antigen
    Journal Article

    Verbel, D. A.; Heller, G.; Kelly, W. K.; Scher, H. I.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements
    Journal Article

    Steineck, G.; Reuter, V.; Kelly, W. K.; Frank, R.; Schwartz, L.; Scher, H. I.
    Acta Oncologica (2002)

    Fulltext@MSK | Save
  • Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration
    Journal Article

    Smaletz, O.; Scher, H. I.; Small, E. J.; Verbel, D. A.; McMillan, A.; Regan, K.; Kelly, W. K.; Kattan, M. W.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer
    Journal Article

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Terry, K. L.; Siedlecki, K.; Swanson, P.; Rafi, M.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • HER-2 profiling and targeting in prostate carcinoma: A phase II trial of trastuzumab alone and with paclitaxel
    Journal Article

    Morris, M. J.; Reuter, V. E.; Kelly, W. K.; Slovin, S. F.; Kenneson, K.; Verbel, D.; Osman, I.; Scher, H. I.
    Cancer (2002)

    Fulltext@MSK | Save